Evidence map›Paper›PMID 31426427›Full record

ArticleNanomaterials (Basel, Switzerland)2019

Synthesis of Magnetic Ferrite Nanoparticles with High Hyperthermia Performance via a Controlled Co-Precipitation Method.

Mohamed S A Darwish, Hohyeon Kim, Hwangjae Lee, Chiseon Ryu, Jae Young Lee, Jungwon Yoon

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 143 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. QCM-Based MgFeNanomaterials (Basel, Switzerland) · 2022
    Article
  18. Effect of TiOMaterials (Basel, Switzerland) · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Mohamed S A DarwishSchool of Integrated Technology, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Hohyeon KimSchool of Integrated Technology, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Hwangjae LeeSchool of Materials Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.
Chiseon RyuSchool of Materials Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.
Jae Young LeeSchool of Materials Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea. jaeyounglee@gist.ac.kr.
Jungwon YoonSchool of Integrated Technology, Gwangju Institute of Science and Technology, Gwangju 61005, Korea. jyoon@gist.ac.kr.
Gwangju Institute of Science and Technology · KR

Funding

National Research Foundation of Korea 2019M3C1B8090798the Korea Evaluation Institute of Industrial Technology (KEIT) grant funded by the Korea government (MOTIE) 20003822
6 · The paper itself

Abstract

Magnetic nanoparticles (MNPs) that exhibit high specific loss power (SLP) at lower metal content are highly desirable for hyperthermia applications. The conventional co-precipitation process has been widely employed for the synthesis of magnetic nanoparticles. However, their hyperthermia performance is often insufficient, which is considered as the main challenge to the development of practicable cancer treatments. In particular, ferrite MNPs have unique properties, such as a strong magnetocrystalline anisotropy, high coercivity, and moderate saturation magnetization, however their hyperthermia performance needs to be further improved. In this study, cobalt ferrite (CoFe

Indexed as

hyperthermiamagnetic ferritemodified co-precipitationspecific loss power

Identifiers

PMID31426427
PMCPMC6724091
OpenAlexW2967889289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.